Sykehuset I Vestfold HF — Clinical Trial Site

38 Registered trials

25 Currently recruiting

Organisation

Sykehuset I Vestfold HF

Location

Toensberg, Norway

Identifier

ORG-100011126

Address

Po Box 2168, 3103, Norway

Departments

..
578001: Oncology
Cancer ad Hematology Center
Cancer and hematology center
Cancer and hematology centre
Cancer center
Clinical Trial unit
Clinical Trial Unit/Center for Cancer and blood diseases
Department for cancer and blood diseases
Department of Infectious Diseases
Department of Medicine
Department of Neurology
Department of Surgery
Division of Mental Health and Addiction, Vestfold Hospital Trust
Hematologisk avdeling
Hematology
Hormon, overvekt og ernæringsavdelingen
Infectious Diseases
Klinikk medisin
Klinikk medisin, Nyreseksjonen
Lungeavdelingen
Lungeavdelningen
Medical Department
Medisinsk Klinikk
Missing
Neurology
of Urology
Oncology
Pediatric
Senter for kreft og blodsykdommer
Urologiska department
Vestfold Hospital

Clinical trials at this site (38)

Search interface

SACK Recruiting

2022-501600-10-00 Atrial fibrillation and Chronic Kidney Disease stage 5 5 2023-02-07
Benzodiazepine stabilizing treatment for patients with benzodiazepine dependence undergoing opioid agonist therapy (BMX-BAR) Recruiting

2023-510404-44-02 Comorbid dependencies to benzodiazepines and opioids 5 2022-10-02
Improving public cancer care by implementing precision medicine in Norway Recruiting

2023-507894-16-00 Cancer 4 2021-04-01
Impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy Recruiting

2024-517854-91-00 Metastatic or high-risk recurrent prostate cancer manag 5 2019-08-05
RElapse from Mrd Negativity As iNdication for Treatment Ended

2023-510215-18-00 Multiple myeloma 10 2024-09-26
A study to test the effect of BI 456906 on cardiovascular safety in people with overweight or obesity Ended

2022-502442-27-00 Obesity 5 2024-01-08
Is there a survival benefit of administering thoracic radiotherapy concurrently with immunnotherapy and chemotherapy for patients with exten… Ended

2023-505514-15-00 Small-cell lung cancer, extensive stage 5 2022-01-11
POLAR BEAR Ended

2022-502887-19-00 Diffuse Large B-Cell Lymphoma 5 2020-08-18
Long-term Efficacy and Safety of Tozorakimab in Participants with Chronic Obstructive Pulmonary Disease with a History of Exacerbations. Ended

2022-501063-41-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2023-04-20
Efficacy and Safety of AXL-Inhibitor bemcentinib for the Treatment of Moderate COVID-19 (AXL-SolidAct) Ended

2022-500363-12-00 SARS CoV-2 (COVID-19) 4 2022-08-24
Cohort study of human mpox virus disease Ended

2022-501132-42-00 Monkeypox virus disease 6 2022-08-02
Study to assess efficacy, safety, and tolerability of Tozorakimab in patients with symptomatic chronic obstructive pulmonary disease (COPD) … Ended

2023-503571-19-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2022-01-20
PARASTOP - Paracetamol with Strong Opioids Ended

2024-515012-53-00 Metastatic cancer disease 5 2021-10-20
European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial (SolidAct) Ended

2022-500385-99-00 SARS-CoV II infection (Coronavirus disease) 5 2021-06-03